Stoxx Europe 50
|
4 967,21
|
-10,51
|
-0,21 %
|
Analysen zu Stoxx Europe 50-Werten
| 11.02.25 | Santander Kaufen | DZ BANK | |
| 11.02.25 | BP Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 11.02.25 | UBS Buy | Deutsche Bank AG | |
| 11.02.25 | BP Buy | UBS AG | |
| 11.02.25 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 11.02.25 | RELX Outperform | Bernstein Research | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Neutral | UBS AG | |
| 11.02.25 | Richemont Buy | UBS AG | |
| 11.02.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 11.02.25 | UBS Outperform | RBC Capital Markets | |
| 11.02.25 | VINCI Outperform | RBC Capital Markets | |
| 11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 11.02.25 | Airbus Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 10.02.25 | Santander Sector Perform | RBC Capital Markets | |
| 10.02.25 | L'Oréal Halten | DZ BANK | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | BAT Buy | UBS AG | |
| 10.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | VINCI Buy | Deutsche Bank AG | |
| 10.02.25 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | L'Oréal Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | Unilever Sell | UBS AG | |
| 10.02.25 | BP Sector Perform | RBC Capital Markets | |
| 10.02.25 | Rio Tinto Neutral | UBS AG | |
| 10.02.25 | L'Oréal Neutral | UBS AG | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 10.02.25 | L'Oréal Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 09.02.25 | BP Buy | Jefferies & Company Inc. | |
| 07.02.25 | ING Group Sector Perform | RBC Capital Markets |
HOT STOCKS DER LETZTEN 3 TAGE
| Unilever | 9 |
| AstraZeneca | 5 |
| BP | 4 |
| VINCI | 3 |
| Shell | 3 |
| TotalEnergies | 3 |
| EssilorLuxottica | 3 |
| GSK | 2 |
| Novo Nordisk | 2 |
| London Stock Exchange | 2 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.